Cancer Nanotechnology

Journal Title：Cancer Nanotechnology

Aim:

Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas.

Scope:

Articles describing original research in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis and treatment of cancer (open submission process). Review, editorial and tutorial articles picking up on subthemes of emerging importance where nanostructures and the induction of nanoscale processes are used for the prevention, diagnosis and treatment of cancer.

目的：

认识到癌症是一组由纳米结构问题（即 DNA）引起的疾病，并且认识到涉及纳米级结构和过程的治疗方法具有独特的优势，因此《癌症纳米技术》杂志旨在传播前沿研究；促进使用纳米结构和诱导纳米级过程预防、诊断和治疗癌症的新兴趋势；并涵盖相关辅助领域。

范围：

描述使用纳米结构和诱导纳米级过程预防、诊断和治疗癌症的原创研究的文章（开放提交流程）。评论、编辑和教程文章，重点介绍新兴重要子主题，其中纳米结构和诱导纳米级过程用于预防、诊断和治疗癌症。

Cancer Nanotechnology创刊于2010年，由Springer Vienna出版商出版，收稿方向涵盖Pharmacology, Toxicology and Pharmaceutics - Pharmaceutical Science全领域，此刊是该细分领域中属于非常不错的SCI期刊，在行业细分领域中学术影响力较大，专业度认可很高，所以对原创文章要求创新性较高，如果您的文章质量很高，可以尝试。平均审稿速度 15 Weeks ，影响因子指数4.5，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。